We can have you start today or have your items shipped out today after the legally required telemedicine consultation
Disclosure of interest: All authors: nothing to disclose Poster session II - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.09 - SEX, GENDER AND STROKE P936 - ESOC25-1649 CEREBRAL VENOUS SINUS THROMBOSIS IN PREGNANT AND PUERPERAL WOMEN Kirsi Rantanen 1 , Liisa Verho 2 , Aino Korhonen 3 , Anna Richardt 1 , Karoliina Aarnio 3 , Hannele Laivuori 4 , Minna Tikkanen 5 , Mika Gissler 6 , Petra Ijs 3 1 Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 2 Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland, 3 Neurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 4 Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Insititute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Department of Obstetrics and Gynecology, Tampere University Hospital, Helsinki Tampere, Finland, 5 Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 6 Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland, Academic Primary Health Care Centre, Region Stockholm, Stockholm, Sweden, Helsinki, Finland Background and Aims: Cerebral venous thrombosis(CVT) is more common among women during pregnancy and puerperium compared to nonpregnant time
Many B1-B6-B12 injections are given intramuscularly (IM), commonly in the gluteal muscle, by a trained professional
BPC-157, derived from human gastric juice, is a stable pentadecapeptide known for its protective, anti-inflammatory, and angiogenic effects
vectibix 100mg 1vial (panitumumab ) Vectibix (panitumumab) is a recombinant, human IgG2 kapp
